Onemednet Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 2.61, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Onemednet in Jun 30 2026 quarter, has decreased to 140 days, compared to 162 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 488 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2853 to 3199.

What is Receivable Turnover Ratio?
What is Onemednet Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ONMD Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	161.42 %	182.19 %	132.39 %	823.81 %	238.67 %
Y / Y Revenue Change	-	-	3326.92 %	-13.38 %	-
Receivable Turnover Ratio (TTM)	2.61	2.25	1.17	-	-
ONMD's Total Ranking	# 3199	# 2853	# 2411	# 0	# 0
Accounts Receivable average collection period days	140	162	312	-	-
Seq. Receivable Change	-4.73 %	40.81 %	-14.95 %	129.13 %	2.83 %
Seq. Revenue Change	2.82 %	-68.13 %	624.39 %	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 29
Healthcare Sector	# 489
Overall Market	# 3199

Receivable Turnover Ratio Statistics
High	Average	Low
10.96	2.28	-1.98
(Sep 30 2024)		(Jun 30 2025)

ONMD Company Profile • Back to ONMD Efficiency Comparisons • Compare ONMD Receivables Turnover Ratio to its Competitors

Financial Statements
Onemednet's Accounts Receivable	$ 1 Millions	Visit ONMD's Balance sheet
Onemednet's Sales TTM	$ 2 Millions	Visit ONMD's Income Statement
Sources of ONMD's Revenues		Visit ONMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ONMD's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ONMD's Growth Rates	ONMD's Roa	ONMD's Inventory Turnover Ratio	ONMD's Dividend Comparisons
ONMD's Profitability Ratios	ONMD's Roi	ONMD's Asset Turnover Ratio	ONMD's Dividend Growth
ONMD's Valuation Ratios	ONMD's Roe	ONMD's Financial Strength Ratios	ONMD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Beone Medicines Ltd	6.58	$ 6,128.238 Millions	$ 930.639 Millions
Embecta Corp	6.57	$ 1,019.700 Millions	$ 155.125 Millions
Editas Medicine Inc	6.57	$ 47.005 Millions	$ 7.156 Millions
Labcorp Holdings Inc	6.49	$ 14,348.000 Millions	$ 2,210.975 Millions
Intellia Therapeutics Inc	6.44	$ 59.506 Millions	$ 9.243 Millions
Cvrx inc	6.44	$ 60.164 Millions	$ 9.345 Millions
Schrodinger Inc	6.43	$ 259.035 Millions	$ 40.267 Millions
Baxter International Inc	6.43	$ 11,555.000 Millions	$ 1,798.000 Millions
Healthcare Services Group Inc	6.42	$ 1,864.594 Millions	$ 290.515 Millions
Verastem Inc	6.42	$ 87.526 Millions	$ 13.640 Millions
Haemonetics Corporation	6.42	$ 1,351.722 Millions	$ 210.662 Millions
Macrogenics Inc	6.41	$ 167.674 Millions	$ 26.170 Millions
Bruker Corporation	6.41	$ 3,498.900 Millions	$ 546.100 Millions
Adaptive Biotechnologies Corporation	6.38	$ 308.081 Millions	$ 48.254 Millions
Iradimed Corporation	6.38	$ 86.339 Millions	$ 13.533 Millions
Aquestive Therapeutics Inc	6.37	$ 54.087 Millions	$ 8.489 Millions
Zoetis Inc	6.32	$ 9,517.000 Millions	$ 1,506.750 Millions
Nuwellis Inc	6.28	$ 9.013 Millions	$ 1.435 Millions
Puma Biotechnology Inc	6.27	$ 231.244 Millions	$ 36.902 Millions
Absci Corp	6.24	$ 1.561 Millions	$ 0.250 Millions
Insulet Corporation	6.24	$ 3,053.400 Millions	$ 489.200 Millions
Heartflow Inc	6.22	$ 210.791 Millions	$ 33.872 Millions
Perrigo Company Plc	6.22	$ 4,144.000 Millions	$ 666.050 Millions
Maxcyte inc	6.22	$ 31.051 Millions	$ 4.994 Millions
Vertex Pharmaceuticals Inc	6.19	$ 12,587.200 Millions	$ 2,032.400 Millions
Orthofix Medical Inc	6.17	$ 833.344 Millions	$ 135.037 Millions
Harvard Bioscience Inc	6.16	$ 88.164 Millions	$ 14.306 Millions
Genedx Holdings Corp	6.16	$ 455.446 Millions	$ 73.962 Millions
Gilead Sciences Inc	6.15	$ 30,457.000 Millions	$ 4,951.000 Millions
Integra Lifesciences Holdings Corp	6.14	$ 1,647.666 Millions	$ 268.153 Millions

Date modified: 2026-09-26T07:39:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.